Currently predicting for Thu, 4 Jun 2026

GNPX Prediction Chart

GNPX Predictions History

Latest community submissions for GNPX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 1, 2025 $0.273 -5.88% $0.275 V 99.15% 3
May 1, 2025 $0.279 -3.67% $0.275 V 98.53% 2
May 1, 2025 Bullish $0.275 X 0
Apr 30, 2025 $0.262 -6.26% $0.290 X 90.51% 0
Apr 30, 2025 $0.269 -3.91% $0.290 X 92.78% 0
Apr 30, 2025 $0.300 +2.39% $0.290 X 96.55% 1
Jan 21, 2025 $0.760 +5.55% $0.695 X 90.69% 0
Jan 21, 2025 $0.745 +3.47% $0.695 X 92.84% 0
Jan 21, 2025 Bullish $0.695 X 0
Nov 19, 2024 $1.52 +11.65% $1.29 X 81.83% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GNPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE